Wall Street analysts forecast that NanoString Technologies, Inc. (NASDAQ:NSTG) will post ($0.48) earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for NanoString Technologies’ earnings, with the lowest EPS estimate coming in at ($0.66) and the highest estimate coming in at ($0.42). NanoString Technologies posted earnings of ($0.55) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 12.7%. The business is scheduled to announce its next earnings report on Wednesday, March 7th.

According to Zacks, analysts expect that NanoString Technologies will report full-year earnings of ($1.90) per share for the current financial year, with EPS estimates ranging from ($2.39) to ($1.27). For the next fiscal year, analysts forecast that the business will report earnings of ($2.25) per share, with EPS estimates ranging from ($3.21) to ($1.06). Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover NanoString Technologies.

NanoString Technologies (NASDAQ:NSTG) last released its earnings results on Thursday, November 2nd. The biotechnology company reported ($0.45) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.56) by $0.11. NanoString Technologies had a negative net margin of 44.24% and a negative return on equity of 174.55%. The business had revenue of $27.02 million during the quarter, compared to analyst estimates of $26.27 million. During the same quarter in the prior year, the firm earned ($0.51) earnings per share. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year.

NSTG has been the subject of a number of research reports. Zacks Investment Research lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, October 17th. Cowen reaffirmed a “buy” rating and set a $20.00 target price on shares of NanoString Technologies in a report on Thursday, September 28th. Janney Montgomery Scott lowered shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a report on Thursday, October 12th. Finally, Robert W. Baird reaffirmed a “buy” rating and set a $14.00 target price on shares of NanoString Technologies in a report on Tuesday, October 24th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $17.25.

Shares of NanoString Technologies (NSTG) opened at $7.29 on Wednesday. NanoString Technologies has a 1-year low of $7.21 and a 1-year high of $23.31. The company has a debt-to-equity ratio of 1.08, a quick ratio of 2.89 and a current ratio of 3.35.

Several institutional investors have recently added to or reduced their stakes in NSTG. SG Americas Securities LLC acquired a new position in shares of NanoString Technologies during the 3rd quarter valued at about $124,000. Bank of Montreal Can boosted its position in shares of NanoString Technologies by 3,731.4% during the 2nd quarter. Bank of Montreal Can now owns 9,387 shares of the biotechnology company’s stock valued at $156,000 after acquiring an additional 9,142 shares during the last quarter. Trexquant Investment LP acquired a new position in shares of NanoString Technologies during the 3rd quarter valued at about $203,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of NanoString Technologies during the 3rd quarter valued at about $222,000. Finally, Bank of America Corp DE boosted its position in shares of NanoString Technologies by 16.6% during the 1st quarter. Bank of America Corp DE now owns 11,404 shares of the biotechnology company’s stock valued at $227,000 after acquiring an additional 1,627 shares during the last quarter. 92.72% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/06/brokerages-expect-nanostring-technologies-inc-nstg-will-post-earnings-of-0-48-per-share.html.

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Get a free copy of the Zacks research report on NanoString Technologies (NSTG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.